Vertex makes $10B deal for commercial endocrinology biotech Crinetics

Vertex Pharmaceuticals is making the largest acquisition in its history, beefing up its commercial portfolio with a $10 billion takeover of Crinetics Pharmaceuticals. The Monday afternoon deal for Crinetics will give ...